- Home
- ASTC vs SNSE Comparison
ASTC vs SNSE Comparison
Compare ASTC & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- SNSE
- Stock Information
- Founded
- ASTC 1984
- SNSE 2005
- Country
- ASTC United States
- SNSE United States
- Employees
- ASTC N/A
- SNSE N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- ASTC Industrials
- SNSE Health Care
- Exchange
- ASTC Nasdaq
- SNSE Nasdaq
- Market Cap
- ASTC 9.9M
- SNSE 9.3M
- IPO Year
- ASTC 1995
- SNSE 2021
- Fundamental
- Price
- ASTC $5.82
- SNSE $0.30
- Analyst Decision
- ASTC
- SNSE Strong Buy
- Analyst Count
- ASTC 0
- SNSE 4
- Target Price
- ASTC N/A
- SNSE $4.25
- AVG Volume (30 Days)
- ASTC 2.9K
- SNSE 135.8K
- Earning Date
- ASTC 05-13-2025
- SNSE 05-06-2025
- Dividend Yield
- ASTC N/A
- SNSE N/A
- EPS Growth
- ASTC N/A
- SNSE N/A
- EPS
- ASTC N/A
- SNSE N/A
- Revenue
- ASTC $903,000.00
- SNSE N/A
- Revenue This Year
- ASTC N/A
- SNSE N/A
- Revenue Next Year
- ASTC N/A
- SNSE N/A
- P/E Ratio
- ASTC N/A
- SNSE N/A
- Revenue Growth
- ASTC N/A
- SNSE N/A
- 52 Week Low
- ASTC $5.75
- SNSE $0.25
- 52 Week High
- ASTC $12.29
- SNSE $0.87
- Technical
- Relative Strength Index (RSI)
- ASTC 45.48
- SNSE 38.30
- Support Level
- ASTC $5.75
- SNSE $0.27
- Resistance Level
- ASTC $6.12
- SNSE $0.33
- Average True Range (ATR)
- ASTC 0.15
- SNSE 0.04
- MACD
- ASTC 0.01
- SNSE -0.00
- Stochastic Oscillator
- ASTC 17.52
- SNSE 34.37
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).